CYP21A2 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with CYP21A2 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with CYP21A2 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with CYP21A2 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CYP21A2 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000187091 - phospholipase C delta 1

Gene

ENSG00000163207 - involucrin

Gene

ENSG00000153802 - transmembrane serine protease 11D

Gene

ENSG00000162980 - ARF like GTPase 5A

Gene

ENSG00000165457 - folate receptor beta

Gene

ENSG00000105538 - Ras interacting protein 1

Gene

ENSG00000034693 - peroxisomal biogenesis factor 3

Gene

ENSG00000114737 - cytokine inducible SH2 containing protein

Gene

ENSG00000171711 - defensin beta 4A

  • Gene

    ENSG00000187091 - phospholipase C delta 1


  • Gene

    ENSG00000163207 - involucrin


  • Gene

    ENSG00000153802 - transmembrane serine protease 11D


  • Gene

    ENSG00000162980 - ARF like GTPase 5A


  • Gene

    ENSG00000165457 - folate receptor beta


  • Gene

    ENSG00000105538 - Ras interacting protein 1


  • Gene

    ENSG00000034693 - peroxisomal biogenesis factor 3


  • Gene

    ENSG00000114737 - cytokine inducible SH2 containing protein


  • Gene

    ENSG00000171711 - defensin beta 4A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.